Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity (Q41006162)

25 September 2017

title

Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity (English)

1 reference

25 September 2017

0 references

1 reference

9

Liaw YF

0 references

author name string

Tsai SL

1

1 reference

25 September 2017

Chen YM

2

1 reference

25 September 2017

Chen MH

3

1 reference

25 September 2017

Huang CY

4

1 reference

25 September 2017

Sheen IS

5

1 reference

25 September 2017

Yeh CT

6

1 reference

25 September 2017

Huang JH

7

1 reference

25 September 2017

Kuo GC

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 October 1998

1 reference

25 September 2017

1 reference

25 September 2017

volume

115

1 reference

25 September 2017

issue

4

1 reference

25 September 2017

page(s)

954-965

1 reference

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Virus escape from CTL recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Purification and characterization of a naturally processed hepatitis B virus peptide recognized by CD8+ cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Displacement of hepatitis B virus by hepatitis C virus as the cause of continuing chronic hepatitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

DNA sequence analysis with a modified bacteriophage T7 DNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Lack of Protective Immunity Against Reinfection with Hepatitis C Virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Genetic organization and diversity of the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

The Taiwanese hepatitis C virus genome: Sequence determination and mapping the 5′ termini of viral genomic and antigenomic RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Comparative studies of the core gene products of two different hepatitis C virus isolates: two alternative forms determined by a single amino acid substitution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Differential subcellular localization of hepatitis C virus core gene products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Characterization of T Cell Clones Specific to a Determinant of Hepatitis B Virus Core and e Antigens in Chronic Type B Hepatitis: Implication for a T Cell Mechanism of HBV Immunopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Analysis of rearranged T cell receptor (TCR) V beta transcripts in livers of primary biliary cirrhosis: preferential V beta usage suggests antigen-driven selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Rearrangements of genes for the antigen receptor on T cells as markers of lineage and clonality in human lymphoid neoplasms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Genes of the T-cell antigen receptor in normal and malignant T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

T cell receptor antagonists and partial agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Essential flexibility in the T-cell recognition of antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Cytotoxic T lymphocyte lysis inhibited by viable HIV mutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

T-cell receptor variable gene products and early HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

The repertoire of T cells shaped by a single MHC/peptide ligand.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Association of malaria parasite population structure, HLA, and immunological antagonism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Antagonists or altruists: do viral mutants modulate T-cell responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Apoptosis by death factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

The tumor necrosis factor ligand and receptor families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Vaccination of chimpanzees against infection by the hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Induction of broadly cross-reactive cytotoxic T cells recognizing an HIV-1 envelope determinant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5085%2898%2970268-9

7 January 2021

10.1016/S0016-5085(98)70268-9

Identifiers

DOI

1 reference

25 September 2017

1 reference